Linalool and β-pinene exert their antidepressant-like activity through the monoaminergic pathway

Life Sciences

Volumn 128, Issue , 2015, Pages 24-29

  Guzmán Gutiérrez, Silvia Laura ^a,b,c   Bonilla Jaime, Herlinda ^a   Gómez Cansino, Rocío ^b   Reyes Chilpa, Ricardo ^b  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c Jalisco   (Mexico)

Author keywords

Antidepressant; Aromatic compounds; Linalool; Monoterpenes; Pinene

Indexed keywords

BETA PINENE; LINALOOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTOXIN; PROPRANOLOL; SEROTONIN 1A RECEPTOR; YOHIMBINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANTIDEPRESSANT AGENT; BENZAZEPINE DERIVATIVE; BETA-PINENE; BICYCLO COMPOUND; IMIPRAMINE; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN ANTAGONIST; TERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; FORCED SWIM TEST; MALE; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; ADRENERGIC NERVE CELL; ANIMAL; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; PHYSIOLOGY; SEROTONINERGIC NERVE CELL;

ANIMALIA; MUS;

ADRENERGIC NEURONS; ANIMALS; ANTIDEPRESSIVE AGENTS; BENZAZEPINES; BICYCLO COMPOUNDS; DOPAMINERGIC NEURONS; IMIPRAMINE; MALE; MICE, INBRED ICR; MONOTERPENES; PIPERAZINES; PYRIDINES; SEROTONERGIC NEURONS; SEROTONIN ANTAGONISTS;

EID: 84925045021     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.02.021     Document Type: Article

References (31)

1. 1A agonists in the treatment of depression? Biol. Psychiatry 53 2003 193 203
2. N.D.C. Jimenez-Perez, F.G. Lorea-Hernandez, C.K. Jankowski, and R. Reyes-Chilpa Essential oils in Mexican bays (Litsea spp., Lauraceae): taxonomic assortment and ethnobotanical implications Econ. Bot. 65 2011 178 189
3. S.L. Guzman-Gutierrez, R. Gomez-Cansino, J.C. Garcia-Zebadua, N.C. Jimenez-Perez, and R. Reyes-Chilpa Antidepressant activity of Litsea glaucescens essential oil: identification of beta-pinene and linalool as active principles J. Ethnopharmacol. 143 2012 673 679
4. V. Coelho, L. Mazzardo-Martins, D.F. Martins, A.R. Santos, L.F. da Silva Brum, J.N. Picada, and P. Pereira Neurobehavioral and genotoxic evaluation of (-)-linalool in mice J. Nat. Med. 67 2013 876 880
5. J.J. Schildkraut The catecholamine hypothesis of affective disorders: a review of supporting evidence J. Neuropsychiatr. Clin. Neurosci. 7 1995 524 533
6. 2 receptors Eur. J. Pharmacol. 578 2008 43 50
7. T. Cassano, S. Gaetani, M.G. Morgese, T. Macheda, L. Laconca, P. Dipasquale, J. Taltavull, T.S. Shippenberg, V. Cuomo, and G. Gobbi Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion Neurochem. Res. 34 2009 1417 1426
8. M. Herrera-Ruiz, Y. Garcia-Beltran, S. Mora, G. Diaz-Veliz, G.S. Viana, J. Tortoriello, and G. Ramirez Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans J. Ethnopharmacol. 107 2006 53 58
9. M. Martinez-Vazquez, R. Estrada-Reyes, A. Martinez-Laurrabaquio, C. Lopez-Rubalcava, and G. Heinze Neuropharmacological study of Dracocephalum moldavica L. (Lamiaceae) in mice: sedative effect and chemical analysis of an aqueous extract J. Ethnopharmacol. 141 2012 908 917
10. E. Penn, and D.K. Tracy The drugs don't work? Antidepressants and the current and future pharmacological management of depression Ther. Adv. Psychopharmacol. 2 2012 179 188
11. E. Elisabetsky, L.F. Brum, and D.O. Souza Anticonvulsant properties of linalool in glutamate-related seizure models Phytomedicine 6 1999 107 113
12. E. Elisabetsky, J. Marschner, and D.O. Souza Effects of linalool on glutamatergic system in the rat cerebral cortex Neurochem. Res. 20 1995 461 465
13. Y. Sugawara, A. Shigetho, M. Yoneda, T. Tuchiya, T. Matumura, and M. Hirano Relationship between mood change, odour and its physiological effects in humans while inhaling the fragrances of essential oils as well as linalool and its enantiomers Molecules 18 2013 3312 3338
14. C. Da Porto, and D. Decorti Analysis of the volatile compounds of flowers and essential oils from Lavandula angustifolia cultivated in northeastern Italy by headspace solid-phase microextraction coupled to gas chromatography-mass spectrometry Planta Med. 74 2008 182 187
15. J. Patora, T. Majda, J. Gora, and B. Klimek Variability in the content and composition of essential oil from lemon balm (Melissa officinalis L.) cultivated in Poland Acta Pol. Pharm. 60 2003 395 400
16. F.D. Yocca Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors J. Clin. Psychopharmacol. 10 1990 6S 12S
17. X.O. Zhu, and N. McNaughton The interaction of serotonin depletion with anxiolytics and antidepressants on reticular-elicited hippocampal RSA Neuropharmacology 33 1994 1597 1605
18. G.P. Luscombe, K.F. Martin, L.J. Hutchins, J. Gosden, and D.J. Heal Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors Br. J. Pharmacol. 108 1993 669 677
19. N. Haddjeri, P. Blier, and C. de Montigny Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors J. Neurosci. 18 1998 10150 10156
20. B. Dell'Osso, M.C. Palazzo, L. Oldani, and A.C. Altamura The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects CNS Neurosci. Ther. 17 2011 723 732
21. M.J. Millan The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review Eur. J. Pharmacol. 500 2004 371 384
22. M. Bourin, M.-C. Colombel, M. Malinge, and J. Bradwejn Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity J. Psychiatry Neurosci. 16 1991 199 203
23. L. Cervo, and R. Samanin Clonidine causes antidepressant-like effects in rats by activating alpha 2-adrenoceptors outside the locus coeruleus Eur. J. Pharmacol. 193 1991 309 313
24. M.F. O'Neill, D.J. Osborne, S.M. Woodhouse, and M.W. Conway Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice J. Psychopharmacol. 15 2001 18 22
25. I. Yalcin, F. Aksu, S. Bodard, S. Chalon, and C. Belzung Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system Behav. Pharmacol. 18 2007 623 631
26. B.E. Leonard Noradrenaline in basic models of depression Eur. Neuropsychopharmacol. 7 1997 S11 S16
27. A. Harkin, R. Nally, J.P. Kelly, and B.E. Leonard Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression J. Neural Transm. 107 2000 1213 1227
28. M. Papp, V. Klimek, and P. Willner Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression Psychopharmacology 114 1994 309 314
29. A. van Waarde, W. Vaalburg, P. Doze, F.J. Bosker, and P.H. Elsinga PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage? Curr. Pharm. Des. 10 2004 1519 1536
30. S.E. Hopwood, C.A. Owesson, L.F. Callado, D.P. McLaughlin, and J.A. Stamford Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function J. Psychopharmacol. 15 2001 147 153
31. P.S. D'Aquila, A.T. Peana, V. Carboni, and G. Serra Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine Eur. J. Pharmacol. 399 2000 43 47